whi p154 has been researched along with E coli Infections in 1 studies
WHI P154: an anti-leukemic agent; structure in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Malaviya, R | 1 |
| Navara, C | 1 |
| Uckun, FM | 1 |
1 other study available for whi p154 and E coli Infections
| Article | Year |
|---|---|
Augmentation of mast cell bactericidal activity by the anti-leukemic drug, 4-(3'bromo-4'-hydroxylphenyl)-amino-6,7-dimethoxyquinazoline.
Topics: Adjuvants, Immunologic; Animals; Cells, Cultured; Drug Evaluation, Preclinical; Escherichia coli; Es | 2002 |